HollyElizabethRawizzaMD

Infectious Disease • Boston, MA

Research Fellow in Medicine, Brigham and Women's Hospital

Join to view full profile

Dr. Rawizza is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Rawizza's full profile

Already have an account?

Office
Brigham and Women's Hospital
75 Francis Street
Boston, MA 02115
Phone+1 617-432-4686
Is this information wrong?

Education & Training

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2005 - 2008
Duke University HospitalResidency, Internal Medicine/Pediatrics, 2001 - 2005
Vanderbilt University School of MedicineClass of 2001

Certifications & Licensure

MA State Medical License 2007 - 2024
NC State Medical License 2001 - 2005
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Clinical Trials

Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin Start of enrollment: 2023 Jul 07
Recruiting
Phase 1
Roles: Principal Investigator, Contact
Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention Start of enrollment: 2024 May 01
Not yet recruiting
Phase 1
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

Pretreatment and Acquired Drug Resistance in Children With Human Immunodeficiency Virus Type 1 in Jos, Nigeria.
Augustine O Ebonyi, Jonathan Okpokwu, Holly Rawizza, Philippe Chebu, Beth Chaplin, Donald Hamel, Stephen Oguche, Oche O Agbaji, Atiene S Sagay, Phyllis J Kanki, Godwin...> ;Open Forum Infectious Diseases. 2024 Mar 1
Timeliness of Point-of-Care Viral Load Results Improves Human Immunodeficiency Virus Monitoring in Nigeria.
Beth Chaplin, Oche Agbaji, Harry Reyes Nieva, Bola Olatunde, Charlotte Chang, Kiren Mitruka, Halima Sule, Titus Dajel, Aaron Zee, Mukhtar L Ahmed, Isah Ahmed, Prosper ...> ;Clinical Infectious Diseases. 2023 Feb 8
1 citations
Rifabutin pharmacokinetics and safety among TB/HIV-coinfected children receiving lopinavir/ritonavir-containing second-line ART
Holly Rawizza, Regina E. Oladokun, Emeka U. Ejeliogu, Stephen Oguche, Babatunde O. Ogunbosi, Oche Agbaji, Georgina N. Odaibo, Godwin E. Imade, David O. Olaleye, Lubbe ...> ;The Journal of Antimicrobial Chemotherapy. 2021 Feb 11
7 citations
Characterisation of HIV-1 Molecular Epidemiology in Nigeria: Origin, Diversity, Demography and Geographic Spread.
Jamirah Nazziwa, Nuno R. Faria, Beth Chaplin, Holly Rawizza, Phyllis J. Kanki, Patrick Dakum, Alash'le Abimiku, Man Charurat, Nicaise Ndembi, Joakim Esbjörnsson> ;Scientific Reports. 2020 Feb 26
4 citations
Pharmacokinetics of adjusted-dose 8-hourly lopinavir/ritonavir in HIV-infected children co-treated with rifampicin.
Helena Rabie, Holly Rawizza, Peter Zuidewind, Jana Winckler, Heather J. Zar, Annelies Van Rie, Lubbe Wiesner, Helen McIlleron> ;The Journal of Antimicrobial Chemotherapy. 2019 Aug 1
6 citations
Safety and efficacy of rifabutin among HIV/TB-coinfected children on lopinavir/ritonavir-based ART.
Holly Rawizza, Kristin M. Darin, Regina E. Oladokun, Biobele J. Brown, Babatunde O. Ogunbosi, Nkiruka David, Sulaimon Akanmu, Oluremi Olaitan, Charlotte A. Chang, Kimb...> ;The Journal of Antimicrobial Chemotherapy. 2019 Sep 1
4 citations
INCIDENCE OF ANAEMIA AMONG HIV-INFECTED PATIENTS TREATED WITH ZIDOVUDINE-CONTAINING ANTIRETROVIRAL THERAPY IN NORTHEASTERN NIGERIA.
N Y Ikunaiye, B A Denue, B A Aina, R Aderemi-Williams, H E Rawizza> ;Annals of Ibadan Postgraduate Medicine. 2018 Dec 1
4 citations
Distinct Pattern of Thymidine Analogue Mutations with K65R in Patients Failing Tenofovir-Based Antiretroviral Therapy.
ChaplinBeth, ImadeGodwin, OnwuamahChika, OdaiboGeorgina, AuduRosemary, OkpokwuJonathan, OlaleyeDavid, MeloniSeema, RawizzaHolly, MuazuMohammad, Z MusaAdesola, SamuelJa...> ;AIDS Research and Human Retroviruses. 2017 Nov 30
2 citations
Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options
Seema T. Meloni, Chika K. Onwuamah, Oche Agbaji, Beth Chaplin, David O. Olaleye, Rosemary A. Audu, Jay Osi Samuels, Oliver Ezechi, Godwin E. Imade, Adesola Z. Musa, Ge...> ;Open Forum Infectious Diseases. 2017 Nov 2
On the Cusp.
Erik H. Knelson, Anand Vaidya, Holly E. Rawizza, Muthiah Vaduganathan, Patrick T. O'Gara> ;The New England Journal of Medicine. 2017 May 24
Triple-drug antiretroviral therapy results in lower HIV maternal-fetal transmission rates but increased adverse effects compared with zidovudine alone
Holly Rawizza> ;The Journal of Pediatrics. 2017 Mar 1
2 citations
Out of Sight: Culture-Negative Endocarditis and Endophthalmitis.
Caitlin M Dugdale, Sarah Brown, Carine Davila, Natalie Wolkow, Gregory A. Fishbein, Jennifer K. Sun, Ebrahim Barkoudah, Holly Rawizza> ;The American Journal of Medicine. 2017 Feb 1
18 citations
Tuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria
Charlotte A. Chang, Seema T. Meloni, Geoffrey Eisen, Beth Chaplin, Patrick Akande, Prosper Okonkwo, Holly Rawizza, Eric J. Tchetgen Tchetgen, Phyllis J. Kanki> ;Open Forum Infectious Diseases. 2015 Dec 1
12 citations
Superior Effectiveness of Zidovudine Compared with Tenofovir When Combined with Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort
Kimberly K. Scarsi, Geoffrey Eisen, Kristin M. Darin, Seema T. Meloni, Holly Rawizza, Eric J. Tchetgen Tchetgen, Oche Agbaji, D. I. Onwujekwe, Wadzani Gashau, Reuben N...> ;Clinical Infectious Diseases. 2015 Nov 10
35 citations
Loss to Follow-Up within the Prevention of Mother-to-Child Transmission Care Cascade in a Large ART Program in Nigeria
Holly Rawizza, Charlotte A. Chang, Beth Chaplin, Isah A. Ahmed, Seema T. Meloni, Tinuade Oyebode, Bolanle Banigbe, Atiene S. Sagay, Isaac F. Adewole, Prosper Okonkwo, ...> ;Current HIV Research. 2015 May 1
7 citations
Patterns of Adherence and Loss to Follow-Up in Pediatric Patients on ART in Nigeria.
Seema T. Meloni, Beth Chaplin, Charlotte A. Chang, Holly Rawizza, Prosper Okonkwo, Phyllis J. Kanki> ;Current HIV Research. 2015 May 1
38 citations
Time-Dependent Predictors of Loss to Follow-Up in a Large HIV Treatment Cohort in Nigeria
Seema T. Meloni, Charlotte A. Chang, Beth Chaplin, Holly Rawizza, Oluwatoyin Jolayemi, Bolanle Banigbe, Prosper Okonkwo, Phyllis J. Kanki> ;Open Forum Infectious Diseases. 2014 Sep 1
33 citations
Accumulation of Protease Mutations among Patients Failing Second-Line Antiretroviral Therapy and Response to Salvage Therapy in Nigeria
Holly Rawizza, Beth Chaplin, Seema T. Meloni, Kristin M. Darin, Oluremi Olaitan, Kimberly K. Scarsi, Chika K. Onwuamah, Rosemary A. Audu, Philippe Chebu, Godwin E. Ima...> ;Plos One. 2013 Sep 17
3 citations
Sputum smear concentration may misidentify acid-fast bacilli as Mycobacterium tuberculosis in HIV-infected patients.
Lana Dinic, Oni E. Idigbe, Seema T. Meloni, Holly Rawizza, Patrick Akande, Geoffrey Eisen, Dan I Onwujekwe, Oche Agbaji, Agatha Ani, Phyllis J. Kanki> ;Journal of Acquired Immune Deficiency Syndromes. 2013 Jun 1
116 citations
Immunologic Criteria Are Poor Predictors of Virologic Outcome: Implications for HIV Treatment Monitoring in Resource-Limited Settings
Holly Rawizza, Beth Chaplin, Seema T. Meloni, Geoffrey Eisen, Tara Rao, Jean-Louis Sankalé, Abdoulaye Dieng-Sarr, Oche Agbaji, D. I. Onwujekwe, Wadzani Gashau, Reuben ...> ;Clinical Infectious Diseases. 2011 Dec 15
3 citations
Pharmacokinetic interactions between ritonavir-boosted darunavir and NNRTIs: a report of 3 cases.
Holly Rawizza, Paul E. Sax> ;The AIDS Reader. 2008 Sep 1
Join now to see all